News & Perspective

Nov 24, 2009

Nov 24, 2009

Novartis unveils US cell-based flu vaccine plant

(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.

Apr 29, 2009

Apr 29, 2009

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Apr 12, 2006

Apr 12, 2006

Top official predicts reduced bird flu impact in US

(CIDRAP News) – The spread of avian flu to the United States probably would not have the same impact it has had in less developed countries, according to the US government's top infectious-disease official.

Feb 28, 2006

Feb 28, 2006

Avian flu suspected in ducks in Sweden, cat in Germany

(CIDRAP News) – Europe braced for further spread of the H5N1 avian influenza virus today in the wake of reports that the virus was suspected in the deaths of two wild ducks on Sweden's Baltic coast and a domestic cat in Germany.

The cat was discovered last weekend on Ruegen, the island off Germany's north coast where H5N1 was first discovered on German soil, according to a Reuters report.

Jun 27, 2005

Jun 27, 2005

Momentum builds for cell-culture flu vaccines

(CIDRAP News) – You've got to gather a lot of eggs to supply the world with influenza vaccine, but that might change before long.

Jun 07, 2005

Jun 07, 2005

Ebola, Marburg vaccines work in monkeys

(CIDRAP News) – A pair of vaccines created by a Canadian-based international team of researchers protected monkeys against the lethal Ebola and Marburg viruses, according to a new report in Nature Medicine.

Apr 20, 2004

Apr 20, 2004

SARS vaccine using vaccinia looks good in mice

(CIDRAP News) – Federal government researchers have reported promising results in animal testing of a candidate SARS (severe acute respiratory syndrome) vaccine that combines a weakened form of vaccinia virus with a gene from the SARS coronavirus.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»